David Skarsgard

555 total citations
25 papers, 450 citations indexed

About

David Skarsgard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, David Skarsgard has authored 25 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in David Skarsgard's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Neuroendocrine Tumor Research Advances (4 papers). David Skarsgard is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Neuroendocrine Tumor Research Advances (4 papers). David Skarsgard collaborates with scholars based in Canada and United States. David Skarsgard's co-authors include Jon Tonita, Patricia Tai, Ali El‐Gayed, Nadeem Pervez, Jackson Wu, R. Pearcey, Edward Yu, Scott Tyldesley, Victor Tsang and Peter L. Munk and has published in prestigious journals such as PLoS ONE, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

David Skarsgard

25 papers receiving 434 citations

Peers

David Skarsgard
Michael A. Samuels United States
Aydın Yavuz Türkiye
Jennifer Novak United States
Jos de Jong Netherlands
Mónica Ramos Spain
Hanjie Shen United States
Judi van Diessen Netherlands
Kathryn Monson United Kingdom
Ameish Govindarajan United States
Elizabeth Maher United Kingdom
Michael A. Samuels United States
David Skarsgard
Citations per year, relative to David Skarsgard David Skarsgard (= 1×) peers Michael A. Samuels

Countries citing papers authored by David Skarsgard

Since Specialization
Citations

This map shows the geographic impact of David Skarsgard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Skarsgard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Skarsgard more than expected).

Fields of papers citing papers by David Skarsgard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Skarsgard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Skarsgard. The network helps show where David Skarsgard may publish in the future.

Co-authorship network of co-authors of David Skarsgard

This figure shows the co-authorship network connecting the top 25 collaborators of David Skarsgard. A scholar is included among the top collaborators of David Skarsgard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Skarsgard. David Skarsgard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yang, et al.. (2024). Outcomes of patients receiving urgent palliative radiotherapy for advanced lung cancer: an observational study. BMC Palliative Care. 23(1). 296–296. 1 indexed citations
2.
Huang, Kitty, Robyn Banerjee, Brock Debenham, et al.. (2021). Novel imaging classification system of nodal disease in human papillomavirus‐mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes. Head & Neck. 43(6). 1854–1863. 3 indexed citations
3.
Dawe, David E., Xibiao Ye, Piotr Czaykowski, et al.. (2018). The effect of statin use on the incidence of prostate cancer: A population‐based nested case–control study. International Journal of Cancer. 143(1). 190–198. 15 indexed citations
4.
Martell, Kevin, Roderick H.W. Simpson, & David Skarsgard. (2016). Solitary Myocardial Metastasis from Locoregionally Controlled Squamous Cell Carcinoma of the Oral Cavity. Cureus. 8(6). e650–e650. 5 indexed citations
5.
Taggar, Amandeep, Roderick H.W. Simpson, Desirée Hao, et al.. (2016). Secondary Neuroendocrine Carcinoma Following High-Dose Radiotherapy for Head and Neck Cancer: Report of Two Cases. Cureus. 8(10). e847–e847. 3 indexed citations
6.
Harris, Jeffrey, Harold Lau, Neil Chua, et al.. (2014). Health Care Delivery for Head-and-Neck Cancer Patients in Alberta: A Practice Guideline. Current Oncology. 21(5). 704–714. 12 indexed citations
7.
Tai, Patricia, et al.. (2012). Treatment Outcomes in Non-Metastatic Prostate Cancer Patients With Ultra-High Prostate-Specific Antigen. International Journal of Radiation Oncology*Biology*Physics. 83(4). e525–e530. 8 indexed citations
8.
Wu, Jackson, Penelope M. A. Brasher, Ali El‐Gayed, et al.. (2012). Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4Gy per fraction. Radiotherapy and Oncology. 103(2). 210–216. 20 indexed citations
9.
Mahmud, Salaheddin M., Eduardo L. Franco, Donna Turner, et al.. (2011). Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study. PLoS ONE. 6(1). e16412–e16412. 42 indexed citations
10.
Scrimger, Rufus, Derek Liu, Mohamed Mohamed, et al.. (2011). Dose–volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: A prospective multi-institutional trial. Radiotherapy and Oncology. 99(2). 101–107. 29 indexed citations
11.
Skarsgard, David, Ali El‐Gayed, R. Pearcey, et al.. (2010). Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers. Radiation Oncology. 5(1). 52–52. 55 indexed citations
12.
13.
Tonita, Jon, David Skarsgard, & Nazeem Muhajarine. (2008). Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era. Cancer Causes & Control. 20(2). 201–209. 2 indexed citations
14.
Feldman‐Stewart, Deb, et al.. (2006). A randomized controlled trial comparing two educational booklets on prostate cancer.. PubMed. 13(6). 3321–6. 12 indexed citations
15.
Tai, Patricia, Jon Tonita, Edward Yu, & David Skarsgard. (2003). Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factors. International Journal of Radiation Oncology*Biology*Physics. 56(3). 626–633. 31 indexed citations
16.
Tai, Patricia, Edward Yu, David Skarsgard, & Jon Tonita. (2003). Validation of the Lognormal Model for Prediction of Long-term Survival Rates from Short-term Follow up Data in Stages III and IV Breast Cancer. Current Oncology. 10(3). 191–194. 2 indexed citations
17.
Feldman‐Stewart, Deb, et al.. (2003). Evaluation of a question-and-answer booklet on early-stage prostate-cancer. Patient Education and Counseling. 49(2). 115–124. 14 indexed citations
18.
Skarsgard, David & Jon Tonita. (2000). Prostate cancer in Saskatchewan Canada, before and during the PSA era. Cancer Causes & Control. 11(1). 79–88. 25 indexed citations
19.
Skarsgard, David, Patti A. Groome, William J. Mackillop, et al.. (2000). Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer. 88(7). 1728–1738. 70 indexed citations
20.
Tyldesley, Scott, et al.. (1996). The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 36(5). 1205–1209. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Samuels Breakdown of academic impact, for papers by Aydın Yavuz Breakdown of academic impact, for papers by Jennifer Novak Breakdown of academic impact, for papers by Jos de Jong Breakdown of academic impact, for papers by Mónica Ramos Breakdown of academic impact, for papers by Hanjie Shen Breakdown of academic impact, for papers by Judi van Diessen Breakdown of academic impact, for papers by Kathryn Monson Breakdown of academic impact, for papers by Ameish Govindarajan Breakdown of academic impact, for papers by Elizabeth Maher
Rankless by CCL
2026